AstraZeneca reports 19% revenue increase and strategic investments in Fusion and Amolyt, highlights strong demand for key products.
PSFK Earnings Call: / AstraZeneca AZN
PSFK Earnings Call: / AstraZeneca AZN
PSFK Earnings Call: / AstraZeneca AZN
AstraZeneca reports 19% revenue increase and strategic investments in Fusion and Amolyt, highlights strong demand for key products.